These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 7904611)

  • 1. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
    Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E
    Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
    Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.
    Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
    Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
    Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
    Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
    Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
    J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
    Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
    Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
    Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
    Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group.
    Niccoli P; Wion-Barbot N; Caron P; Henry JF; de Micco C; Saint Andre JP; Bigorgne JC; Modigliani E; Conte-Devolx B
    J Clin Endocrinol Metab; 1997 Feb; 82(2):338-41. PubMed ID: 9024213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma.
    Erdoğan MF; Güllü S; Başkal N; Uysal AR; Kamel N; Erdoğan G
    J Clin Endocrinol Metab; 1997 Mar; 82(3):897-9. PubMed ID: 9062503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma.
    Perdrisot R; Bigorgne JC; Guilloteau D; Jallet P
    Clin Chem; 1990 Feb; 36(2):381-3. PubMed ID: 2302785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
    Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.